Alnylam Pharmaceuticals
ALNY
#601
Rank
โ‚ฌ35.56 B
Marketcap
266,51ย โ‚ฌ
Share price
2.28%
Change (1 day)
18.62%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: 418,91ย โ‚ฌ Euro on 2025-10-20

Lowest end of day price: 3,37ย โ‚ฌ Euro on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2026

Annual Stock Price Performance

Year Performance
2026-23.16%
2025 70.21%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
123,51ย โ‚ฌ-0.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
39,39ย โ‚ฌ-1.26%๐Ÿ‡ซ๐Ÿ‡ท France
638,93ย โ‚ฌ-0.31%๐Ÿ‡บ๐Ÿ‡ธ USA
17,69ย โ‚ฌ 2.17%๐Ÿ‡บ๐Ÿ‡ธ USA
6,96ย โ‚ฌ 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
1,04ย โ‚ฌ-1.22%๐Ÿ‡บ๐Ÿ‡ธ USA
26,70ย โ‚ฌ 2.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
63,58ย โ‚ฌ 0.87%๐Ÿ‡บ๐Ÿ‡ธ USA